Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.9

-1.54

-1.19

-0.84

Details

Expected EPS

-0.8750285696000001

Actual EPS

-0.8363320000000001

Surprise EPS

0.04

Surprise Percent

+4.42%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -0.8363320000000001 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.